These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18034585)

  • 21. Multimodality management of localized pancreatic cancer.
    Wayne JD; Wolff RA; Pisters PW; Evans DB
    Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical results and indications for adjuvant measures in pancreatic cancer].
    Beger HG; Büchler MW; Friess H
    Chirurg; 1994 Apr; 65(4):246-52. PubMed ID: 7912665
    [No Abstract]   [Full Text] [Related]  

  • 23. [ASCO 2006 Gastrointestinal Cancers Symposium, San Francisco, 26-28 January 2006].
    Tumori; 2006; 92(2):1-20. PubMed ID: 16724704
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy for pancreatic cancer.
    Morris SL; Beasley M; Leslie M
    N Engl J Med; 2004 Jun; 350(26):2713-5; author reply 2713-5. PubMed ID: 15215490
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for pancreatic cancer.
    Bydder S; Spry N
    N Engl J Med; 2004 Jun; 350(26):2713-5; author reply 2713-5. PubMed ID: 15218576
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress.
    Evans DB; Wolff RA
    Ann Surg Oncol; 2011 May; 18(5):1224-8. PubMed ID: 21384245
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.
    Cooperman AM; Snady H; Bruckner HW; Hammerman H; Siegel J; Stark B; Bank S
    Surg Clin North Am; 2001 Jun; 81(3):699-708. PubMed ID: 11459283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evidence does not support the use of adjuvant radiotherapy in pancreatic cancer.
    Neoptolemos JP
    Nat Clin Pract Oncol; 2008 Aug; 5(8):431. PubMed ID: 18668027
    [No Abstract]   [Full Text] [Related]  

  • 30. The current status of combined radiotherapy and chemotherapy for locally advanced or resected pancreas cancer.
    Mulcahy MF; Wahl AO; Small W
    J Natl Compr Canc Netw; 2005 Sep; 3(5):637-42. PubMed ID: 16194455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibilities and limits of cytostatic chemotherapy in pancreatic carcinoma].
    Scheithauer W
    Wien Klin Wochenschr; 1994; 106(22):704-8. PubMed ID: 7825320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings.
    Dickler A; Abrams RA
    Semin Radiat Oncol; 2005 Oct; 15(4):235-44. PubMed ID: 16183477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant radiochemotherapy in pancreatic cancer: contra.
    Henne-Bruns D; Staib L
    Front Radiat Ther Oncol; 2004; 38():76-81. PubMed ID: 15458190
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant therapy for pancreatic cancer--the debate continues.
    Choti MA
    N Engl J Med; 2004 Mar; 350(12):1249-51. PubMed ID: 15028829
    [No Abstract]   [Full Text] [Related]  

  • 35. [Postoperative adjuvant chemotherapy for resectable pancreatic cancer].
    Uesaka K
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(4):308-312. PubMed ID: 32281571
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
    Berlin JD
    Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
    Abrams RA; Yeo CJ
    Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant pancreatic cancer therapy: no one should go it alone or be left behind.
    Herman JM; Regine WF
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):645-7. PubMed ID: 20510192
    [No Abstract]   [Full Text] [Related]  

  • 39. Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation.
    Wayne JD; Abdalla EK; Wolff RA; Crane CH; Pisters PW; Evans DB
    Oncologist; 2002; 7(1):34-45. PubMed ID: 11854545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.